By analyzing patient survival data, we discovered that levels of DEF6 expression in COREAD were abnormally high and that patients with high levels of expression had considerably worse prognoses, indicating that DEF6 expression may have a unique role in promoting cancer in this disease. This evidence concerns the gene DEF6 and cancer.